Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease

被引:11
|
作者
Pachima, Yanina Ivashko [1 ,2 ]
Zhou, Liu-yao [3 ,4 ]
Lei, Peng [3 ,4 ,5 ]
Gozes, Illana [1 ,2 ]
机构
[1] Tel Aviv Univ, Lily & Avraham Gildor Chair Invest Growth Factors, Dept Human Mol Genet & Biochem,Adams Super Ctr Br, Elton Lab Neuroendocrinol,Sackler Fac Med, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Neurol, Chengdu 610041, Sichuan, Peoples R China
[4] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[5] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Unit, Parkville, Vic 3052, Australia
基金
中国国家自然科学基金; 以色列科学基金会;
关键词
DEPENDENT NEUROPROTECTIVE PROTEIN; AMYLOID-BETA-PROTEIN; PAIRED HELICAL FILAMENT; SIGNAL-REGULATED KINASE; FAST AXONAL-TRANSPORT; NAP DAVUNETIDE; MOUSE MODEL; NEURONAL DIFFERENTIATION; ENDOGENOUS TAU; DRUG CANDIDATE;
D O I
10.1007/s12031-016-0715-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [41] CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease
    Horie, Kanta
    Barthelemy, Nicolas R.
    Sato, Chihiro
    Bateman, Randall J.
    BRAIN, 2021, 144 (02) : 515 - 527
  • [42] Interaction of Alzheimer's disease amyloid β peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain
    Pérez, M
    Cuadros, R
    Benítez, MJ
    Jiménez, JS
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (05) : 461 - 467
  • [43] Clusterin is a Potential Therapeutic Target in Alzheimer's Disease
    Palihati, Nazhakaiti
    Tang, Yuanhong
    Yin, Yajuan
    Yu, Ding
    Liu, Gang
    Quan, Zhenzhen
    Ni, Junjun
    Yan, Yan
    Qing, Hong
    MOLECULAR NEUROBIOLOGY, 2023, 61 (7) : 3836 - 3850
  • [44] Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease
    Waragai, Masaaki
    Ho, Gilbert
    Takamatsu, Yoshiki
    Wada, Ryoko
    Sugama, Shuei
    Takenouchi, Takato
    Masliah, Eliezer
    Hashimoto, Makoto
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (04) : 1249 - 1253
  • [45] The GABAergic system as a therapeutic target for Alzheimer's disease
    Calvo-Flores Guzman, Beatriz
    Vinnakota, Chitra
    Govindpani, Karan
    Waldvogel, Henry J.
    Faull, Richard L. M.
    Kwakowsky, Andrea
    JOURNAL OF NEUROCHEMISTRY, 2018, 146 (06) : 649 - 669
  • [46] ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease
    Lanfranco, Maria Fe
    Ng, Christi Anne
    Rebeck, G. William
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19
  • [47] ApoE Remodeling as a Therapeutic Target for Alzheimer's Disease
    Ladu, Mary Jo
    Avila-Munoz, Maria Evangelina
    Valencia-Olvera, Ana
    Ghura, Shivesh
    Collins, Nicole
    Balu, Deebika
    York, Jason
    FASEB JOURNAL, 2017, 31
  • [48] NADPH oxidase as a therapeutic target in Alzheimer's disease
    Block, Michelle L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [49] Ferroptosis, a Potential Therapeutic Target in Alzheimer's Disease
    Chen, Kai
    Jiang, Xiaobing
    Wu, Moxin
    Cao, Xianming
    Bao, Wendai
    Zhu, Ling-Qiang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9